Navigation Links
Money for Biomedical Research Cut in Recent Years
Date:1/15/2010

New review provides data on sources of public and private funds

FRIDAY, Jan. 15 (HealthDay News) -- From 2005 to 2008, the level of funding for biomedical research in the United States appears to have decreased by 2 percent, a new study shows.

The same review also found that the rate of increase in funding has slowed since 2005.

An analysis of data showed that funding of biomedical research by federal, state and local government, and private and industry sources increased from $75.5 billion in 2003 to $101.1 billion in 2007, an inflation-adjusted increase of 14 percent.

"In our previous study, funding increased at a compound annual growth rate of 7.8 percent for 1994-2003 compared with a compound annual rate of 3.4 percent for 2003-2007," wrote Dr. E. Ray Dorsey, of the University of Rochester Medical Center in Rochester, N.Y., and colleagues.

For 2008, biomedical funding data were available only for the U.S. National Institutes of Health (NIH) and industry. The total was $88.8 billion.

"The corresponding total for 2007 for the NIH and industry was $86.4 billion and when adjusted to 2008 dollars is $90.2 billion, indicating that real [adjusted for inflation] funding for biomedical research from the NIH and industry decreased from $90.2 billion in 2007 to $88.8 billion in 2008," the researchers wrote.

Industry was the largest contributor to biomedical research in 2007 (58 percent), while the NIH was the second-largest contributor (27 percent). From 2003 to 2007, inflation-adjusted funding from pharmaceutical, biotechnology and medical device companies increased 25 percent, while NIH funding decreased by 8.6 percent and total federal government funding increased by 0.7 percent, the study found.

In 2007, the United States spent about 4.5 percent of its total health expenditures on biomedical research. From 2003 to 2008, there was no increase in the number of new drugs and medical devices approved by the U.S. Food and Drug Administration.

"Biomedical research is valued highly by individuals, governments, foundations and corporations. Research is seen as a source of more effective treatments and preventive measures and as a route to political policy, economic development, and new commercial products," the study authors wrote.

"While the promise of new drugs for refractory common or devastating diseases continues to capture the public's imagination and enjoys strong support, policy makers are also aware that new beneficial technology often spawns new cost. Consequently, timely and accurate information about the sources of public and private research funds is important," they added.

The study is published in the Jan. 13 issue of the Journal of the American Medical Association.

More information

The National Association for Biomedical Research has more about the benefits of biomedical research.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, Jan. 12, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter
2. Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes
3. Psychotherapy Can Boost Happiness More Than Money: Study
4. MISSION Skincare(R) Supports GNCs Efforts To Raise Money for St. Jude Childrens Research Hospital(R)
5. New Breast Cancer Recommendation May Cost Lives While Saving Money
6. Doc Fix NOT What The Doctor Ordered; National Physician Group OPPOSES Pay Raise in House; Failed in Senate, Still a Bad Idea in the House; Payoff to AMA? New Survey Shows Money is Not Primary Concern of Doctors
7. AutoTrader.com to Raise Money for St. Jude Childrens Research Hospital(R)
8. GlucoStories Donation Campaign Aims to Raise Diabetes Awareness and Money for Diabetes Causes
9. The American Medical Money Machine, the Destruction of Healthcare in America and the Rise of Medical Tourism, a New Book by James R. Goldberg
10. Money Woes Keeping Many Couples From Fertility Treatments
11. AUDIO from Medialink and OptumHealth: Learn How You Can Save Money on Healthcare this One Time of Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: